ProPhase Labs, Inc. Competitors

PRPH 
$1.52
*  
unch
unch
Get PRPH Alerts
*Delayed - data as of Aug. 27, 2014 10:29 ET  -  Find a broker to begin trading PRPH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PRPH Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

ProPhase Labs, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Abbott Laboratories
ABT: NYSE
$ 42.61 -0.19 ▼ 511,246 $ 42.88
$ 42.51
$ 43.27
$ 32.70
28.03 64,072,614,390
AbbVie Inc.
ABBV: NYSE
$ 55.545 -0.21 ▼ 2,373,299 $ 55.85
$ 55.43
$ 58.27
$ 42.26
21.45 88,410,920,955
ACADIA Pharmaceuticals Inc.
ACAD: NASDAQ-GS
$ 23.82 0.01 ▲ 119,467 $ 23.989
$ 23.50
$ 32
$ 15.64
NE 2,357,608,320
Acasti Pharma, Inc.
ACST: NASDAQ-CM
$ .9401 0.00 ▲ 14,525 $ .95
$ .937
$ 2.95
$ .80
NE 99,520,866
AcelRx Pharmaceuticals, Inc.
ACRX: NASDAQ-GM
$ 6.97 -0.02 ▼ 198,694 $ 7.045
$ 6.87
$ 13.64
$ 6.04
NE 301,912,520
Achaogen, Inc.
AKAO: NASDAQ-GM
$ 9 0.04 ▲ 5,589 $ 9.0599
$ 8.92
$ 19.69
$ 8.64
NE 159,390,000
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 11.63 -0.12 ▼ 4,714,187 $ 11.82
$ 11.15
$ 12.059
$ 2.26
NE 1,125,737,480
Actavis, Inc.
ACT: NYSE
$ 226.26 -1.46 ▼ 182,613 $ 227.80
$ 225.68
$ 230.77
$ 136.52
491.87 59,791,693,860
Acura Pharmaceuticals, Inc.
ACUR: NASDAQ-CM
$ .9283 0.01 ▲ 44,055 $ 1
$ .9235
$ 2.23
$ .8121
NE 45,345,598
Adamas Pharmaceuticals, Inc.
ADMS: NASDAQ-GM
$ 17.924 -0.28 ▼ 525 $ 18.18
$ 17.64
$ 21.6299
$ 12.02
NE 300,370,392
Adamis Pharmaceuticals Corporation
ADMP: NASDAQ-CM
$ 3.75 -0.13 ▼ 16,173 $ 3.89
$ 3.7355
$ 7.25
$ 2.62
NE 39,382,500
Advaxis, Inc.
ADXS: NASDAQ-CM
$ 3.80 0.07 ▲ 101,543 $ 3.86
$ 3.69
$ 11.70
$ 2.46
NE 73,237,400
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 1.386 0.02 ▲ 4,758 $ 1.4275
$ 1.21
$ 2.63
$ .75
NE 5,738,040
Aegerion Pharmaceuticals, Inc.
AEGR: NASDAQ-GS
$ 32.52 1.55 ▲ 553,319 $ 32.75
$ 31.32
$ 101
$ 26.25
NE 958,787,160
AEterna Zentaris Inc.
AEZS: NASDAQ-CM
$ 1.325 0.02 ▲ 191,716 $ 1.33
$ 1.31
$ 1.75
$ .99
NE 74,881,050
Agile Therapeutics, Inc.
AGRX: NASDAQ-GM
$ 7.10 -0.38 ▼ 10,834 $ 7.45
$ 7.06
$ 12.55
$ 5.05
NE 132,010,300
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 45.16 0.68 ▲ 19,766 $ 45.39
$ 44.3901
$ 50.37
$ 15.77
NE 1,533,452,960
Akebia Therapeutics, Inc.
AKBA: NASDAQ-GM
$ 23.01 -0.30 ▼ 4,740 $ 23.28
$ 22.9863
$ 31
$ 16.41
NE 466,251,630
Akorn, Inc.
AKRX: NASDAQ-GS
$ 38.77 -0.25 ▼ 196,701 $ 39.28
$ 38.50
$ 39.48
$ 17.77
96.92 4,029,055,940
Alcobra Ltd.
ADHD: NASDAQ-GM
$ 20.164 -0.45 ▼ 55,807 $ 20.9895
$ 19.74
$ 26.96
$ 12.04
NE 274,976,468
Alder BioPharmaceuticals, Inc.
ALDR: NASDAQ-GM
$ 17.02 0.03 ▲ 2,954 $ 17.44
$ 17
$ 22.95
$ 9.50
NE 524,284,080
Aldeyra Therapeutics, Inc.
ALDX: NASDAQ-CM
$ 3.575 -0.03 ▼ 1,194 $ 3.59
$ 3.575
$ 8.2223
$ 3
NE 19,894,875
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 170.09 -2.18 ▼ 244,205 $ 172.72
$ 169.581
$ 185.43
$ 100.89
85.47 33,643,121,640
Alexza Pharmaceuticals, Inc.
ALXA: NASDAQ-GM
$ 3.49 -0.02 ▼ 21,196 $ 3.5655
$ 3.47
$ 5.93
$ 3.4101
NE 60,446,800
Alimera Sciences, Inc.
ALIM: NASDAQ-GM
$ 5.735 0.09 ▲ 39,445 $ 5.85
$ 5.70
$ 8.44
$ 1.65
NE 231,269,610